Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Philip Rubin, MD, FASTRO: Reflections on a Radiation Oncology Pioneer.

Constine LS, Chen Y.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):193-5. doi: 10.1016/j.ijrobp.2015.02.002. No abstract available.

PMID:
25968815
2.

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, Nathan PC, Tissing WJ, Shankar S, Sieswerda E, Skinner R, Steinberger J, van Dalen EC, van der Pal H, Wallace WH, Levitt G, Kremer LC.

Lancet Oncol. 2015 Mar;16(3):e123-36. doi: 10.1016/S1470-2045(14)70409-7. Review.

PMID:
25752563
3.

Radiotherapy Quality Assurance Report From Children's Oncology Group AHOD0031.

Dharmarajan KV, Friedman DL, FitzGerald TJ, McCarten KM, Constine LS, Chen L, Kessel SK, Iandoli M, Laurie F, Schwartz CL, Wolden SL.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1065-71. doi: 10.1016/j.ijrobp.2014.11.034. Epub 2015 Feb 7.

PMID:
25670539
4.

Second primary head and neck cancer after Hodgkin lymphoma: A population-based study of 44,879 survivors of Hodgkin lymphoma.

Chowdhry AK, McHugh C, Fung C, Dhakal S, Constine LS, Milano MT.

Cancer. 2015 May 1;121(9):1436-45. doi: 10.1002/cncr.29231. Epub 2015 Jan 8.

PMID:
25572913
5.

Patterns of Relapse From a Phase 3 Study of Response-Based Therapy for Intermediate-Risk Hodgkin Lymphoma (AHOD0031): A Report From the Children's Oncology Group.

Dharmarajan KV, Friedman DL, Schwartz CL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):60-6. doi: 10.1016/j.ijrobp.2014.10.042. Epub 2014 Dec 24.

PMID:
25542311
6.

A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.

Gawade PL, Hudson MM, Kaste SC, Neglia JP, Wasilewski-Masker K, Constine LS, Robison LL, Ness KK.

Curr Pediatr Rev. 2014;10(4):249-62.

PMID:
25403639
7.

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313.

Persky DO, Miller TP, Unger JM, Spier CM, Puvvada S, Stea BD, Press OW, Constine LS, Barton KP, Friedberg JW, LeBlanc M, Fisher RI.

Blood. 2015 Jan 8;125(2):236-41. doi: 10.1182/blood-2014-06-584623. Epub 2014 Nov 13.

PMID:
25395425
8.

Protons, the brainstem, and toxicity: ingredients for an emerging dialectic.

Yock TI, Constine LS, Mahajan A.

Acta Oncol. 2014 Oct;53(10):1279-82. doi: 10.3109/0284186X.2014.957415. No abstract available.

PMID:
25327262
9.

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.

Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL.

J Clin Oncol. 2014 Nov 10;32(32):3651-8. doi: 10.1200/JCO.2013.52.5410. Epub 2014 Oct 13.

PMID:
25311218
10.

ACR appropriateness criteria follow-up of Hodgkin lymphoma.

Ha CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, Younes A, Constine LS.

J Am Coll Radiol. 2014 Nov;11(11):1026-1033.e3. doi: 10.1016/j.jacr.2014.07.038. Epub 2014 Sep 30.

PMID:
25278496
11.

Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population.

Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS.

Pediatr Blood Cancer. 2014 Nov;61(11):1955-60. doi: 10.1002/pbc.25149. Epub 2014 Aug 17.

PMID:
25130403
12.

Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.

Youn P, Milano MT, Constine LS, Travis LB.

Cancer. 2014 Aug 1;120(15):2334-42. doi: 10.1002/cncr.28733. Epub 2014 Apr 18.

PMID:
24752471
13.

ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma.

Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS.

Pediatr Blood Cancer. 2014 Jul;61(7):1305-12. doi: 10.1002/pbc.24983. Epub 2014 Feb 24. Review.

PMID:
24616347
14.

A systematic review of dental late effects in survivors of childhood cancer.

Gawade PL, Hudson MM, Kaste SC, Neglia JP, Constine LS, Robison LL, Ness KK.

Pediatr Blood Cancer. 2014 Mar;61(3):407-16. doi: 10.1002/pbc.24842. Epub 2013 Nov 1. Review.

15.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

Health Phys. 2014 Feb;106(2):229-46. doi: 10.1097/HP.0000000000000013. Review.

PMID:
24378498
16.

The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents.

Shayne M, Culakova E, Milano MT, Dhakal S, Constine LS.

J Cancer Surviv. 2014 Jun;8(2):167-72. doi: 10.1007/s11764-013-0328-0. Epub 2013 Dec 5.

PMID:
24307557
17.

Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Mulder RL, Kremer LC, Hudson MM, Bhatia S, Landier W, Levitt G, Constine LS, Wallace WH, van Leeuwen FE, Ronckers CM, Henderson TO, Dwyer M, Skinner R, Oeffinger KC; International Late Effects of Childhood Cancer Guideline Harmonization Group.

Lancet Oncol. 2013 Dec;14(13):e621-9. doi: 10.1016/S1470-2045(13)70303-6.

18.

Pleural effusions in patients with Hodgkin lymphoma: clinical predictors and associations with outcome.

Hunter BD, Dhakal S, Voci S, Goldstein NP, Constine LS.

Leuk Lymphoma. 2014 Aug;55(8):1822-6. doi: 10.3109/10428194.2013.836599. Epub 2014 Feb 4.

PMID:
24237578
19.

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.

Stiff PJ, Unger JM, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS, Miller TP, Tubbs RR, Marcellus D, Friedberg JW, Barton KP, Mills GM, LeBlanc M, Rimsza LM, Forman SJ, Fisher RI.

N Engl J Med. 2013 Oct 31;369(18):1681-90. doi: 10.1056/NEJMoa1301077.

20.

ACR Appropriateness Criteria: Localized nodal indolent lymphoma.

Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS.

Oncology (Williston Park). 2013 Aug;27(8):786-94.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk